• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cornerstone Therapeutics Inc

+ Add to Watchlist


Price not available for DUJ1:GR

Snapshot for Cornerstone Therapeutics Inc (DUJ1)

Open: - Day's Range: - Volume: 0
Previous Close: 6.969 52wk Range: - 1-Yr Rtn: -

Stock Chart for DUJ1

No chart data available.
  • DUJ1:GR 6.969
  • 1M
  • 1Y
Interactive DUJ1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DUJ1

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DUJ1

No data available

Company Profile & Key Executives for DUJ1

Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body's inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.

Craig A CollardChief Executive Ofcr/FounderKenneth R McBean "Ken"President
Alastair S McEwanCFO/Treasurer/SecretaryJoshua B Franklin "Josh"VP:Strategy/Investor Relations
More Company Profile & Key Executives for DUJ1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil